# INMB (Inmune Bio Inc.) - SEC EDGAR Financial Statements

> Inmune Bio Inc. reported $50K in revenue and a net loss of $16.67M for the fiscal year ended December 31, 2025 (up 257.1% year over year), with a -35542.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/INMB
- Markdown: https://convexityos.com/fundamentals/INMB.md
- SEC CIK: 0001711754
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001711754&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $50K | +257.1% YoY |
| Operating Income | FY 2025 | -$17.77M | -35542.0% margin |
| Net Income | FY 2025 | -$16.67M | -33332.0% net margin |
| Diluted EPS | FY 2025 | -$0.60 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$23.62M | -47248.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: $1.21M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $50K | $14K | $155K | $374K | $181K | $11K | -- | $0 | $0 |
| Research & Development | $20.66M | $33.17M | $20.27M | $17.07M | $20.54M | $5.92M | $3.28M | $3.35M | $435K |
| Total Operating Expenses | $47.43M | $42.65M | $29.90M | $26.32M | $29.33M | $12.24M | $7.76M | $12.44M | $981K |
| **Operating Income** | -$47.38M | -$42.63M | -$29.74M | -$25.95M | -$29.15M | -$12.23M | -$7.76M | -$12.44M | -$981K |
| **EBITDA** | -$47.30M | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest Income | -- | -- | -- | -- | -- | -- | $78K | -- | -- |
| Interest Expense | $0 | $357K | $2.28M | $2.01M | $985K | -- | -- | -- | -- |
| Income Before Tax | $45.93M | $42.08M | $30.01M | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Net Income** | -$45.93M | -$42.08M | -$30.01M | -$27.30M | -$30.34M | -$12.10M | -$7.68M | -$12.44M | -$831K |
| Basic EPS | -$1.86 | -$2.11 | -$1.67 | -$1.52 | -$1.88 | -$1.01 | -$0.75 | -$1.43 | -$0.13 |
| **Diluted EPS** | -$1.86 | -$2.11 | -$1.67 | -$1.52 | -$1.88 | -$1.01 | -$0.75 | -$1.43 | -$0.13 |
| Basic Shares Outstanding | 24.8M | 19.9M | 18.0M | 17.9M | 16.1M | 12.0M | 10.3M | 8.7M | 6.6M |
| Diluted Shares Outstanding | 24.8M | 19.9M | 18.0M | 17.9M | 16.1M | 12.0M | 10.3M | 8.7M | 6.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $0 | $50K | $0 |
| Research & Development | -- | -- | $3.64M | $2.33M | $4.89M | $5.80M | $7.64M | $7.35M |
| Total Operating Expenses | $5.01M | $1.48M | $5.81M | $5.47M | $7.43M | $24.57M | $9.96M | $9.47M |
| **Operating Income** | -$5.01M | -$1.48M | -$5.81M | -$5.47M | -$7.43M | -$24.57M | -$9.90M | -$9.47M |
| **EBITDA** | -$4.91M | -$1.38M | -$5.76M | -- | -- | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | -- | $250K | $0 | -$395K |
| **Net Income** | -$4.72M | -$1.27M | -$5.41M | -$5.26M | -$6.47M | -$24.46M | -$9.74M | -$9.22M |
| Basic EPS | -$0.17 | -$0.05 | -$0.20 | -- | -$0.24 | -$1.05 | -$0.43 | -- |
| **Diluted EPS** | -$0.17 | -$0.05 | -$0.20 | -- | -$0.24 | -$1.05 | -$0.43 | -- |
| Basic Shares Outstanding | 27.8M | 26.7M | 26.6M | -- | 26.6M | 23.3M | 22.5M | -- |
| Diluted Shares Outstanding | 27.8M | 26.7M | 26.6M | -- | 26.6M | 23.3M | 22.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $24.75M | $20.92M | $35.85M | $52.15M | $74.81M | $21.97M | $7.00M | $186K | $1.37M |
| **Cash & Short-Term Investments** | $24.75M | $20.92M | $35.85M | $52.15M | $74.81M | $21.97M | $7.00M | $186K | $1.37M |
| Accounts Receivable, Net | $4.28M | $1.18M | $1.91M | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $29.89M | $22.66M | $39.94M | $64.67M | $82.61M | $23.99M | $7.76M | $849K | $1.90M |
| Property, Plant & Equipment, Net | $955K | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | -- | $16.51M | $16.51M | $16.51M | $16.51M | $16.51M | $16.51M | $16.51M | $16.51M |
| Other Non-Current Assets | $595K | $79K | $131K | $99K | $99K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $2.46M | $16.90M | $17.06M | $17.12M | $17.34M | $16.67M | $16.71M | $16.51M | $16.51M |
| **Total Assets** | $32.35M | $39.56M | $57.00M | $81.80M | $99.94M | $40.66M | $24.47M | $17.36M | $18.41M |
| Short-Term Debt | -- | -- | $9.92M | $5.00M | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | $517K | $489K | $616K | $474K | $190K | -- | -- | -- |
| **Total Current Liabilities** | $8.42M | $7.22M | $18.46M | $10.92M | $4.36M | $1.78M | $700K | $824K | -- |
| Long-Term Debt | -- | $15.00M | -- | $9.70M | $15.00M | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $411K | $244K | $397K | $10.77M | $15.36M | $126K | $160K | $0 | -- |
| **Total Liabilities** | $8.83M | $7.46M | $18.86M | $21.69M | $19.72M | $1.90M | $861K | $824K | $310K |
| **Total Debt (incl. Leases)** | $1.03M | $15.38M | $10.44M | $15.31M | $15.42M | $168K | $168K | -- | -- |
| Common Stock | $27K | $22K | $18K | $18K | $18K | $13K | $11K | $8.7K | $8.3K |
| Retained Earnings | -$209.0M | -$163.1M | -$121.0M | -$91.01M | -$63.72M | -$33.38M | -$21.28M | -$13.60M | -$1.16M |
| Accumulated Other Comp. Income | -$737K | -$575K | -$799K | -$699K | $1.0K | $11K | -$8.5K | $6.5K | $32K |
| **Total Stockholders' Equity** | $23.52M | $32.10M | $37.34M | $60.10M | $80.22M | $38.75M | $23.61M | $16.54M | $18.10M |
| Total Equity | $23.52M | $32.10M | $37.34M | $60.10M | $80.22M | $38.75M | $23.61M | $16.54M | $18.10M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $24.75M | $27.73M | $33.37M | $19.34M | $20.92M |
| **Cash & Short-Term Investments** | -- | -- | -- | $24.75M | $27.73M | $33.37M | $19.34M | $20.92M |
| Accounts Receivable, Net | $1.21M | $4.41M | $479K | $4.28M | $1.70M | $1.60M | $1.28M | $1.18M |
| **Total Current Assets** | $18.71M | $23.80M | $22.82M | $29.89M | $30.67M | $36.03M | $20.96M | $22.66M |
| Property, Plant & Equipment, Net | $1.19M | $1.26M | $903K | $955K | $878K | $706K | -- | -- |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $16.51M | $16.51M |
| Other Non-Current Assets | $531K | $537K | $683K | $595K | $746K | $570K | $49K | $79K |
| **Total Non-Current Assets** | $2.80M | $3.05M | $3.00M | $2.46M | $2.69M | $1.65M | $16.84M | $16.90M |
| **Total Assets** | $21.51M | $26.84M | $25.82M | $32.35M | $33.36M | $37.68M | $37.80M | $39.56M |
| Other Current Liabilities | -- | -- | -- | -- | -- | $511K | $480K | $517K |
| **Total Current Liabilities** | $2.92M | $5.89M | $5.39M | $8.42M | $7.36M | $8.59M | $7.93M | $7.22M |
| Long-Term Debt | -- | -- | -- | -- | -- | $15.00M | $15.00M | $15.00M |
| **Total Non-Current Liabilities** | $518K | $593K | $806K | $411K | $623K | $231K | $201K | $244K |
| **Total Liabilities** | $3.44M | $6.48M | $6.19M | $8.83M | $7.98M | $8.82M | $8.13M | $7.46M |
| **Total Debt (incl. Leases)** | $1.21M | $1.41M | $1.51M | $1.03M | $1.08M | $15.45M | $15.35M | $15.38M |
| Common Stock | $28K | $28K | $27K | $27K | $27K | $27K | $23K | $22K |
| Retained Earnings | -$220.4M | -$215.7M | -$214.4M | -$209.0M | -$203.8M | -$197.3M | -$172.8M | -$163.1M |
| Accumulated Other Comp. Income | -$840K | -$823K | -$727K | -$737K | -$764K | -$763K | -$610K | -$575K |
| **Total Stockholders' Equity** | $18.07M | $20.36M | $19.62M | $23.52M | $25.38M | $28.87M | $29.67M | $32.10M |
| Total Equity | $18.07M | $20.36M | $19.62M | $23.52M | $25.38M | $28.87M | $29.67M | $32.10M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$45.93M | -$42.08M | -$30.01M | -$27.30M | -$30.34M | -$12.10M | -$7.68M | -$12.44M | -$831K |
| Depreciation & Amortization | $84K | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock-Based Compensation | $9.91M | $7.61M | $7.37M | $7.15M | $4.80M | $3.11M | $4.10M | $10.00M | $200K |
| Change in Receivables | -$3.10M | $724K | $6.19M | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$22.58M | -$33.36M | -$11.98M | -$22.69M | -$28.50M | -$8.94M | -$5.38M | -$2.06M | -$762K |
| Capital Expenditure | -$1.04M | -- | -- | -- | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -$23.62M | -- | -- | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$1.04M | -- | -- | -- | -$15.00M | -- | -- | -- | -$100K |
| Common Stock Issued | $27.54M | $27.79M | $775K | $699K | $80.25M | $24.91M | $12.21M | $900K | $2.06M |
| **Financing Cash Flow** | $27.61M | $18.21M | -$4.22M | $729K | $96.36M | $23.89M | $12.21M | $900K | $2.06M |
| **Net Change in Cash** | $3.83M | -$14.93M | -$16.30M | -$22.66M | $52.84M | $14.97M | $6.81M | -$1.18M | $1.23M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.72M | -$1.27M | -$5.41M | -$5.26M | -$6.47M | -$24.46M | -$9.74M | -$9.22M |
| Depreciation & Amortization | $100K | $100K | $52K | -- | -- | -- | -- | -- |
| Stock-Based Compensation | $1.12M | $1.36M | $1.50M | $3.32M | $2.98M | $1.53M | $2.08M | $1.76M |
| Change in Receivables | $3.20M | -$3.93M | $3.81M | -$2.58M | -$99K | -$322K | -$102K | -$72K |
| **Operating Cash Flow** | -$3.39M | -$3.17M | -$3.40M | -$2.94M | -$5.44M | -$7.38M | -$6.82M | -$11.01M |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $22.27M | $5.27M | -- |
| **Financing Cash Flow** | -- | -- | -- | $67K | $0 | $22.27M | $5.27M | -$2.08M |
| **Net Change in Cash** | -$2.08M | -$2.95M | -$3.39M | -$2.98M | -$5.64M | $14.04M | -$1.58M | -$12.63M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -94766.0% | -304535.7% | -19187.7% | -6938.8% | -16106.6% | -111163.6% | -- | -- | -- |
| **Net Profit Margin** | -91866.0% | -300585.7% | -19360.0% | -7299.2% | -16762.4% | -109990.9% | -- | -- | -- |
| Return on Equity (ROE) | -195.3% | -131.1% | -80.4% | -45.4% | -37.8% | -31.2% | -32.5% | -75.2% | -4.6% |
| Return on Assets (ROA) | -142.0% | -106.4% | -52.6% | -33.4% | -30.4% | -29.8% | -31.4% | -71.6% | -4.5% |
| Current Ratio | 3.55x | 3.14x | 2.16x | 5.92x | 18.95x | 13.51x | 11.09x | 1.03x | -- |
| Quick Ratio | 3.45x | 3.06x | 2.04x | 4.78x | 17.16x | 12.37x | 9.99x | 0.23x | -- |
| Debt to Equity | 0.04x | 0.48x | 0.28x | 0.25x | 0.19x | 0.00x | 0.01x | -- | -- |
| **Revenue Growth (YoY)** | +257.1% | -91.0% | -58.6% | +106.6% | +1545.5% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +120.1% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -94766.0% | -102752.0% | -112458.0% | -83046.0% | -304535.7% |
| **Net Profit Margin** | -- | -- | -- | -91866.0% | -99774.0% | -111016.0% | -81592.0% | -300585.7% |
| Return on Equity (ROE) | -92.2% | -90.4% | -212.0% | -195.3% | -196.6% | -192.3% | -137.5% | -131.1% |
| Return on Assets (ROA) | -77.5% | -68.6% | -161.1% | -142.0% | -149.6% | -147.3% | -107.9% | -106.4% |
| Current Ratio | 6.41x | 4.04x | 4.24x | 3.55x | 4.17x | 4.20x | 2.64x | 3.14x |
| Quick Ratio | -- | -- | -- | 3.45x | 4.00x | 4.07x | 2.60x | 3.06x |
| Debt to Equity | 0.07x | 0.07x | 0.08x | 0.04x | 0.04x | 0.54x | 0.52x | 0.48x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | +257.1% | -100.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
